Zobrazeno 1 - 10
of 958
pro vyhledávání: '"Second Malignancy"'
Autor:
Yoshihiro Masui, Takehito Shukuya, Shunichi Kataoka, Hitomi Shiozaki, Kana Kurokawa, Ikuko Nakamura, Taichi Miyawaki, Yoshika Koinuma, Tetsuhiko Asao, Ryota Kanemaru, Shoko Sonobe Shimamura, Tomoyasu Mimori, Yoichiro Mitsuishi, Ken Tajima, Naoko Shimada, Kazuhisa Takahashi
Publikováno v:
Thoracic Cancer, Vol 15, Iss 32, Pp 2291-2297 (2024)
Abstract Objectives This study aimed to investigate the characteristics of patients with recurrent or advanced non‐small cell lung cancer (NSCLC) treated with tyrosine kinase inhibitors (TKIs) or immune‐checkpoint inhibitors (ICIs) who developed
Externí odkaz:
https://doaj.org/article/c859515e911947f1a830ca4533f1af24
Autor:
Connor McPartland, Andrew Salib, Joshua Banks, James R. Mark, Costas D. Lallas, Edouard J. Trabulsi, Leonard G. Gomella, Hanan Goldberg, Benjamin Leiby, Robert Den, Thenappan Chandrasekar
Publikováno v:
European Urology Open Science, Vol 63, Iss , Pp 52-61 (2024)
Background and objective: Radiation therapy has increasingly been used in the management of pelvic malignancies. However, the use of radiation continues to pose a risk of a secondary malignancy to its recipients. This study investigates the risk of s
Externí odkaz:
https://doaj.org/article/8fed90a672d84d9b917cc404d3a1c1ed
Autor:
Hanna A.M. Koivisto, Aapeli O. Nevala, Joonas M. Miettinen, Janne M. Pitkäniemi, Nea K. Malila, Sanna M.M. Heikkinen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: The objective of this study was to explore the incidence of second malignant neoplasms (SMNs) among adult cancer patients in Finland diagnosed with their first primary cancer (FPC) in 1992–2021. Material and methods: The st
Externí odkaz:
https://doaj.org/article/22c9806678434095b63f86d80269ac3b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Solid organ malignancies have been reported in survivors of Hodgkin lymphoma treated with chemoradiation; however, to the best of our knowledge no cases of pulmonary synovial sarcoma have been documented in the literature in this cohort. We herein pr
Externí odkaz:
https://doaj.org/article/29f20b137725405e9914ffe0abd003ef
Publikováno v:
Medicina, Vol 59, Iss 8, p 1463 (2023)
Background and Objectives: Radiotherapy (RT) plays an important role in the treatment for locally advanced rectal cancer patients. It can bring radio exposure together with the survival benefit. Cancer survivors are generally at an increased risk for
Externí odkaz:
https://doaj.org/article/1fb0d27f358d4f62aadf5997c32b6220
Autor:
Tomonobu Koizumi, Shintaro Kanda, Ryo Nihonmatu, Daisuke Gomi, Nodoka Sekiguchi, Takuro Noguchi, Toshirou Fukushima, Takashi Kobayashi, Hiroshi Yamamoto, Tetsu Takeda
Publikováno v:
Thoracic Cancer, Vol 12, Iss 6, Pp 807-813 (2021)
Abstract Background This study was performed to clarify the treatment outcome of patients with primary mediastinal germ cell tumors (PMGCTs), focusing on the clinical manifestations and management during definitive therapy and long‐term follow‐up
Externí odkaz:
https://doaj.org/article/058381b6c50a49fa9d0d588278cf51f7
High‐grade B‐cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib
Autor:
Teruhito Takakuwa, Ryota Sakai, Shiro Koh, Hiroshi Okamura, Satoru Nanno, Yasuhiro Nakashima, Takahiko Nakane, Hideo Koh, Masayuki Hino, Hirohisa Nakamae
Publikováno v:
Clinical Case Reports, Vol 9, Iss 3, Pp 1344-1349 (2021)
Abstract Tyrosine kinase inhibitor (TKI) can help to increase the survival time in chronic myeloid leukemia (CML) patients; however, the risk of secondary malignancies due to TKIs is a growing concern. Only few reports showed clinical course of patie
Externí odkaz:
https://doaj.org/article/38340fb4f75c470bb3d7258188f184e7
Autor:
Manette A.W. Dinnessen, Otto Visser, Sanne H. Tonino, Marjolein W.M. van derPoel, Nicole M.A. Blijlevens, Marie José Kersten, Pieternella J. Lugtenburg, Avinash G. Dinmohamed
Publikováno v:
eJHaem, Vol 1, Iss 2, Pp 489-497 (2020)
Abstract We assessed the impact of a prior malignancy diagnosis (PMD) – as a potential proxy for genetic cancer susceptibility – on the development of a second primary malignancy (SPM) and mortality in follicular lymphoma (FL) patients. From the
Externí odkaz:
https://doaj.org/article/dfa9b778bf134e4ab8e827d8c61d9710